MedTrace Logo

Metabolic Syndrome in Patients Undergoing Endovascular Aortic Repair (EVAR)

NCT04152395 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2020-05-27

No results posted yet for this study

Summary

This prospective study aims to identify the prevalence of metabolic syndrome in patients undergoing EVAR and the implications of metabolic syndrome on the postoperative outcome, the major complications, the thromboembolic events and the perioperative mortality and morbidity of the patients undergoing vascular surgery.

Conditions

  • Metabolic Syndrome
  • Endovascular Aortic Repair

Interventions

OTHER

EVAR

Patients undergoing EVAR

Sponsors & Collaborators

  • University of Thessaly

    lead OTHER

Principal Investigators

  • Elena Arnaoutoglou, MD, PhD · University of Thessaly

  • Haralampos Milionis, MD, PhD · University of Ioannina

  • Konstantina Kolonia, MD, PhD · University Hospital of Larissa

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2021-12-11
Completion
2022-12-11

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04152395 on ClinicalTrials.gov